Ensuring all individuals have access to diabetes technology

Competing interests for the authors of this content include receiving research funding from the National Institutes of Health (NIH) and Medtronic Diabetes, as well as being a consultant for Medtronic Diabetes, WebMD, and Calm. Another author has received grants or contracts from the Juvenile Diabetes Research Foundation (JDRF), National Institute of Diabetes and Digestive and Kidney Diseases, Jaeb Center for Health Research, Insulet, Medtronic, Provention Bio, and Abbott paid to her institution. She has also received consulting fees from Abbott, payment or honoraria from Insulet, Medtronic Diabetes, and Zealand Pharma, and has participated in advisory boards for Cecelia Health, Insulet, Mannkind, Medtronic Diabetes, and Vertex Pharmaceuticals. She also reports owning stock/stock options of StartUp Health T1D Moonshot.

These competing interests indicate that the authors have financial relationships with various organizations and companies within the healthcare and diabetes research fields. It is important to take these competing interests into consideration when evaluating the content of their research or publications. Transparency about potential conflicts of interest is crucial for maintaining credibility and trust in the scientific and medical community. By clearly disclosing their competing interests, the authors are providing important information for readers to assess the potential impact on the research findings or recommendations presented in the content.